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Crystal structurePhospholipase A2 (PLA2) is an important component in snake venoms. Here, an acidic PLA2, desig-
nated PA2-Vb was isolated from the Trimeresurus stejnegeri snake venom. PA2-Vb acts on a prote-
ase-activated receptor (PAR-1) to evoke Ca2+ release through the inositol 1,4,5-trisphosphate
receptor (IP3R) and induces mouse aorta contraction. PAR-1, phospholipase C and IP3R inhibitors
suppressed PA2-Vb-induced aorta contraction. The crystal structure reveals that PA2-Vb has the
typical fold of most snake venom PLA2. Several PEG molecules bond to a positively charged pocket.
The ﬁnding offers a novel pharmacological basis of the structure for investigating the PAR-1
receptor and suggests potential applications for PA2-Vb in the vascular system.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Snake venom exhibits a variety of toxic effects including neuro-
toxicity, cardiotoxicity and myotoxicity. By means of toxic effects,
snakes can survive in complex environments [23,26,28,34]. Phos-
pholipase A2 (PLA2) is commonly found in snake venoms as well
as mammalian tissues. Functionally, PLA2 speciﬁcally recognizes
the sn-2 acyl bond of phospholipids and catalytically hydrolyzes
the bond to release arachidonic acid and lysophospholipids
involved in many critical biological processes [14,30]. In snake
venom, PLA2 (svPLA2) also inhibits A-type K+ currents in rat dorsal
root ganglion neurons [12]. Several crystal structure studiessuggest that most svPLA2s share a common set of structural fea-
tures, including their small molecular mass (14–18 kDa) and a
compact structure with seven conserved disulﬁde bonds and an
important Ca2+-loop [21].
Calcium ion signals in vascular smooth muscle cells (VSMCs)
include Ca2+ ﬂashes, oscillations, puffs, ripples, sparkletts, sparks,
waves and rises in the global intracellular Ca2+ level ([Ca2+]i)
[3,40]. The sources of Ca2+ ions are mainly from extracellular
Ca2+ entry and intracellular Ca2+ store release. In vascular smooth
muscle cells (VSMCs), the primary intracellular Ca2+ store is sarco-
plasmic reticulum (SR) [36]. Two common Ca2+ release channels,
the inositol 1,4,5-trisphosphate receptor (IP3R) and the ryanodine
receptor (RyR), are located in the SR membrane [8]. It is well
known that numerous G-protein coupled receptors (GPCRs),
including protease-activated receptor (PAR-1), link to IP3R-medi-
ated Ca2+ release, resulting in a rise in VSMC [Ca2+]i and vasocon-
striction [11]. IP3R regulates VSMC contractility, gene expression,
migration and proliferation by modulating their intracellular Ca2+
homeostasis. Several diseases, including hypertension, atheroscle-
rosis and diabetes-related vascular complications, are linked to the
malfunction of IP3R and the consequent changes in Ca2+ signaling
[24].
The present study describes the puriﬁcation and structural
characteristics of an acidic PLA2, named PA2-Vb, which was iso-
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PAR-1-mediated Ca2+ releasing effect.
2. Materials and methods
2.1. Puriﬁcation of PA2-Vb
PA2-Vb was puriﬁed from the lyophilized crude venom of T. ste-
jnegeri (Tunxi Snakebite Institute, Anhui, China) by a three-step
chromatographic procedure at 14 C as previously described [38].
The detailed methods are described in the supplementary material.
2.2. Enzymatic assays
The enzymatic activity of PA2-Vb was determined using a turbi-
dimetric method with egg yolk phospholipids as a substrate [13].
One egg yolk was suspended in 1 L of physiological saline and
0.2 ml of the suspension was mixed with 0.8 ml 0.1 M Tris, pH
8.0. Then, 0.1 mg of PA2-Vb was added and the mixture was incu-
bated at 30 C. The decrease in the suspension turbidity was mon-
itored, and the absorbance was recorded at 740 nm. One unit was
deﬁned as the amount of enzyme that produced a decrease of 0.01
in absorbance in 10 min. The speciﬁc activity was expressed as U/
mg.
2.3. Isolation of the thoracic aorta and tension measurements
All animal experiments were conducted in accordance with NIH
publication No. 8523 and were approved by the Institutional Ani-
mals Care and Use Committee of Anhui Medical University. The
isolated aortic rings for tension measurements were prepared as
previously described [39]. The detailed method is described in
the supplementary material.
2.4. Reversible permeabilization
Heparin was loaded into the cell using a reversible permeabili-
zation (RP) method [15]. The detailed method is described in the
supplementary material.
2.5. Modiﬁcation by pBPB
His48 in PLA2 was modiﬁed by p-Bromophenacyl Bromide
(pBPB) using a protein to reagent molar ratio of 1:5 [20]. At room
temperature, PA2-Vb (1 mg) was dissolved in 1 ml 25 mM Tris,
pH 8.0, and then 0.4 mM pBPB was added from a stock solution
in acetone. When the residual activity was less than 1%, the
reaction mixture was acidiﬁed to pH 3.0 to quench the reaction.
The unbound pBPB was removed on a desalting column (GE
Healthcare). The pBPB-conjugated PA2-Vb was then applied to
the vessel for tension measurements and enzymatic assays.
2.6. VSMC primary culture and [Ca2+]i measurement
Under a dissecting microscope, the endothelium-denuded aor-
tic strips were placed in an ice-cold PBS solution (137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) and cut into
small blocks (2  2 mm) [25]. These tissue blocks were then pasted
on the bottom of cell culture dishes and cultured in DMEM in a
37 C incubator. After 4–7 days, VSMCs gradually grew out from
the edge of the vessel tissues.
For the [Ca2+]i measurement, the primary cultured VSMCs were
loaded with 10 lM Fluo-8/AM and 0.02% F-127 for 60 min in the
dark at 37 C in an NPSS (140 mM NaCl, 5 mM KCl, 1 mM CaCl2,
10 mM glucose and 5 mM HEPES, pH 7.4 with NaOH). After threewashes with a Ca2+-free NPSS solution, the ﬂuorescence signal of
the VSMCs was measured by a confocal laser scanning microscope
(ZEISS 710, objective EC Plan-Neoﬂuar 10/0.30 M27). The
wavelength of the excitation laser light was 488 nm. The [Ca2+]i
rise was displayed as a ratio of ﬂuorescence intensity relative to
that induced by ATP application (F/FATP).
2.7. Crystallization and data collection
The PA2-Vb was concentrated to 20 mg/ml in 5 mM Tris, 50 mM
NaCl, pH 7.5. Crystallization screens were performed at 14 C by
the hanging-drop vapor-diffusion method with 1 ll protein solu-
tion and 1 ll reservoir solution. Hampton Research Crystal Screens
were used to screen for crystallization conditions. After one week,
high quality rod-shaped crystals appeared in a drop containing 12%
PEG8000, 0.1 M sodium phosphate, pH 6.5 and were obtained for
data collection. A diffraction data set was collected at 100 K with
cryoprotectant solution (reservoir solution supplemented with an
additional 20% (v/v) glycerol) using MAR345 image plate on beam-
line BL17U at the Shanghai Synchrotron Radiation Facility (SSRF)
and was processed to 1.60 Å using HKL2000 [18].
2.8. Model building, sequence determination and reﬁnement of the
crystal structure
The phase of the PA2-Vb crystal was solved by molecular
replacement using Molrep [31] from the CCP4 package [19] using
the structure of the PLA2 from Agkistrodon piscivorus venom (PDB
entry: 1VAP) as the search model [10]. The model completion
was performed in COOT [7] and the reﬁnement was performed
using REFMAC5 [17]. Using the homologous protein sequences,
the amino acid sequence of PA2-Vb was determined in accordance
with the electron density map. For structurally similar amino acids,
we corrected the side chains by comparing the homologous
sequences to the shape of the FO–FC map. The R-factor and free
R-factor of the ﬁnal reﬁned model are 18.3% and 20.9%, respec-
tively. The overall assessment of model quality was checked by
MolProbity [4] and PROCHECK [16]. The atomic coordinates have
been deposited in the Protein Data Bank with accession code
4RFP. Detailed information about data collection and processing
are presented in Table 1. Figures were prepared using PyMOL
(DeLano Scientiﬁc LLC).
2.9. Incubation with heparin
The effect of heparin on the enzymatic activity of PA2-Vb was
determined by pre-incubating the PLA2 with heparin (2.5 lg/lg
of enzyme) for 30 min at 25 C followed by the activity assay.
2.10. Statistical analysis
Results are expressed as the mean values ± the standard devia-
tion (mean ± SD). Statistical analysis between two independent
samples was performed with the student’s t-test. The signiﬁcance
was considered at a level of P < 0.05. In the concentration-response
curves, the data were ﬁtted to the sigmoidal dose-response equa-
tion with a variable Hill slope using Origin software.
3. Results
3.1. Puriﬁcation of PA2-Vb and enzymatic characterization
PA2-Vb was isolated from T. stejnegeri venom by a three-step
chromatographic process (Fig. 1). The SDS–PAGE proﬁle of PA2-Vb
shows a single band of 14 kDa under non-reducing conditions
Table 1
Data collection and reﬁnement statistics for PA2-Vb.
Data collection
Resolution (Å) 50.0–1.60 (1.63–1.60)a
Wavelength (Å) 0.97915
Oscillation width (deg) 1
Exposure time (s) 1
Space group P21212
Unit cell parameters (Å) a = 72.18, b = 85.71, c = 38.89
No. of unique reﬂections 32661 (1659)a
Redundancy 11.0 (11.4)a
Completeness (%) 98.7 (100)a
Average I/r (I) 10.9 (7.5)a
Rmerge
b (%) 16.6 (44.5)a
Reﬁnement
Resolution (Å) 36.85–1.60
No. of reﬂections for reﬁnement/test 30970/1643
Rwork
c (%)/Rfreed (%) 18.3/20.9
Rmsd for bonds (Å) 0.0084
Rmsd for angles (deg) 1.278
Mean B factor (Å2) 24.25
No. of water oxygen atoms 187
Ramachandran plot (%)
Most favored regions 91.3
Additional allowed regions 7.7
Generously allowed regions 1.0





|I|, where Ii is the intensity of an individual reﬂection and





|Fo|, where Fo and Fc are the observed and calculated
structure factors for reﬂections, respectively.
d Rfree was calculated as Rwork using the 5% of reﬂections that were selected
randomly and omitted from reﬁnement.
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onto a C18 reverse-phase HPLC column, which showed PA2-Vb
appearing as a single major peak (Fig. 1d), indicating that the
purity of PA2-Vb was high enough to be used in the subsequent
experiments. As a member of the phospholipase, its enzymaticFig. 1. Puriﬁcation of PA2-Vb from T. stejnegeri venom. (a and b) Q XL and Mono Q chro
numbers indicate the elution markers (in kDa). The inset shows the SDS–PAGE ge
chromatography.activity was tested and the result indicates that PA2-Vb efﬁciently
cleaved egg yolk phospholipids with a speciﬁc enzymatic activity
of 6.8 ± 0.3  104 U/mg (n = 4 independent measurements, Fig. 2).
Conversely, the enzymatic activity of PA2-Vb was strongly inhib-
ited by the treatment with pBPB (Fig. 2). After the incubation of
PA2-Vb with heparin, a slight increase in enzymatic activity was
observed (Fig. 2), which is similar to other snake PLA2s [27].
3.2. Effect of PA2-Vb on vasoconstriction and Ca2+ mobilization in
VSMCs
When snakes attack human beings, the venom is injected into
the human body. The venom diffuses into the circulatory system
and alters blood vessel tension. Therefore, we tested the effect of
PA2-Vb on the vasoconstriction. Endothelium-denuded mouse aor-
tic rings were pre-contracted in a high concentration K+ solution.
After 15 min, 500 nM PA2-Vb was added into the bath. Interest-
ingly, PA2-Vb further contracted the vessel rings with an EC50 of
86 nM (n = 5, the Hill slope is 1.49 ± 0.14, Fig. 3a and b). Because
PA2-Vb is a phospholipase A2, we used pBPB to block its enzymatic
activity. However, the data show that pBPB conjugation did not
alter its effect on the vasoconstriction following the high
K+-induced contraction (Fig. 3d). In another set of experiments,
500 nM PA2-Vb transiently constricted the vessel rings in the
absence of high K+ solution (6.1 ± 1.4% of high K+-induced
constriction, n = 5, Fig. 3c).
Calcium ions are a primary factor for triggering muscle cell con-
traction. In VSMCs, an L-type Ca2+ channel is the main pathway for
mediating extracellular Ca2+ inﬂux. Thus, we used 2 lM nifedipine
to inhibit L-type Ca2+ channels or omitted extracellular Ca2+ ions
(Ca2+-free) to eliminate extracellular Ca2+ inﬂux. However, the
results show that PA2-Vb was still able to induce a transient vaso-
constriction without signiﬁcant inhibition (Fig. 3e). In addition to
the extracellular Ca2+ inﬂux, cytosolic Ca2+ also comes from Ca2+
stores that are released by IP3R and/or RyR. We utilized ryanodine
to block RyR and used 2-aminoethoxy diphenyl borate (2-APB) andmatography. (c) Superdex 200 size-exclusion chromatography. The dashed line and
l image. Lane P, PA2-Vb; lane M, molecular mass markers (in kDa). (d) HPLC
Fig. 2. The effect of the native, heparin pre-incubated and pBPB conjugated PA2-Vb
on egg yolk phospholipids.
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inhibit PA2-Vb-induced vasoconstriction; however, 2-APB and
heparin signiﬁcantly abolished PA2-Vb-induced vasoconstriction.Fig. 3. The contractile effect of PA2-Vb on mouse thoracic aortic rings. (a) Contractile r
Concentration-response curve for the contractile effect. (c) Contractile response induce
showing the pBPB effect on PA2-Vb-induced vasocontraction after 60 mM K+-induced co
the presence of different inhibitors and Ca2+-free assays. RP: reversible permeabilization
experiments). ⁄⁄P < 0.01 compared with the corresponding control group.This result suggests that PA2-Vb-induced vasoconstriction may
be affected by IP3R-mediated Ca2+ release. Therefore, to further
investigate the mechanism, the SR Ca2+ pump inhibitor thapsigargin
was used to deplete the Ca2+ stores. The data indicate that PA2-Vb-
induced vasoconstriction disappeared upon thapsigargin treatment
(Fig. 3e).
Because PA2-Vb is a macromolecule that is too large to trans-
port into VSMCs, PA2-Vb-induced IP3R activity may be through
GPCRs-mediated Ca2+ signaling. We used U73122 to inhibit
phospholipase Cb (PLCb) which is downstream of GPCRs. The result
shows that U73122 abolished PA2-Vb-induced vasocontraction
(Fig. 3e). Interestingly, we also found that the protease activated
receptor-1 (PAR-1) inhibitor SCH79797 signiﬁcantly blocked the
PA2-Vb-induced vasocontraction (Fig. 3e).
To clarify the role of Ca2+ in the PA2-Vb-induced vasocontrac-
tion, intracellular Ca2+ levels were measured. In the primary
culture VSMCs, 500 nM PA2-Vb evoked a transient [Ca2+]i rise
(Fig. 4), while 2-APB dramatically abolished the PA2-Vb-induced
rise in [Ca2+]i (Fig. 4b and c).
3.3. Sequence and structural features of PA2-Vb
Using homologous sequences and the high resolution (1.6 Å) of
the data, the amino acid sequence in the PA2-Vb structure was
determined based on the electron density map (Fig. 5). To show
the quality of the structure, the electron density maps of the repre-
sentative regions including the Ca2+-loop and C-loop are presented
in Fig. 5a and b. The sequence of PA2-Vb has high homology toesponse induced by 500 nM PA2-Vb following 60 mM K+-induced contraction. (b)
d by 500 nM PA2-Vb in normal Krebs Henseleit solution. (d) Summary of the data
ntraction. (e) Summary of the data showing the PA2-Vb-induced vasocontraction in
. K–H: Krebs Henseleit solution. Results are the mean ± S.D. (n = 5 or 8 independent
Fig. 4. PA2-Vb-induced intracellular Ca2+ ([Ca2+]i) rise in vascular smooth muscle cells (VSMCs): (a) Representative ﬂuorescence images of primary cultured VSMCs before
(left) and after (right) 500 nM PA2-Vb treatment. (b and c) Representative traces and summarized data of [Ca2+]i rise induced by 500 nM PA2-Vb in primary cultured VSMCs.
Results are the mean ± S.D. (n = 5 independent experiments). ⁄⁄P < 0.01 compared with the control group.
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PA2-V, which is also isolated from T. stejnegeri snake venom
(Fig. 5c).
The overall structure of PA2-Vb displays the typical fold of a
svPLA2 (Fig. 6a). The crystal has two molecules in the asymmetric
unit. Superposition of the Ca atoms of the two monomers yields
an RMSD of 0.69 Å, indicating the similarity of the two molecules
(A and B). In Protein Data Bank, more than one hundred of struc-
tures of svPLA2 (or complex) have been solved. Using the molecular
A of PA2-Vb as a search model, DALI search [11] showed that PA2-
Vb has a highly conserved structure to other svPLA2s for example
1.0 Å RMSD and 69% sequence identity against 1IJL, an acidic
PLA2 from the venom of Deinagkistrodon acutus [9] and 1.1 Å
RMSD and 69% identity against 1VAP [10]. Similar to other svPLA2s,
PA2-Vb has seven disulﬁde bridges in each monomer with and six
canonical features (Figs. 5c and 6a): (i) an N-terminal a-helix (H1),
(ii) a ‘short’ helix (g1), (iii) a Ca2+-binding loop, (iv) two anti-
parallel a-helices (H2 and H3), (v) two short strands of anti-paral-
lel b-sheet (b-wing), and (vi) a C-terminal loop. In the crystal
structure, four PEG molecules were observed. One of them is
located in the pocket formed by residues Ala13/Arg16/Trp21/
Lys110/Tyr113/Arg114 in monomer A (Fig. 6b). The other three PEG
molecules are located in the same pocket in monomer B (Fig. 6c).
All four of the PEG molecules interact with residues in PA2-Vb
through many hydrogen bonds and hydrophobic interactions.
3.4. Oligomeric assembly
The results of Superdex 200 chromatography indicate that PA2-
Vb is predominantly in a monomer in solution. But a signiﬁcant
homodimer peak was also observed (Fig. 1c). The SDS–PAGEanalysis of PA2-Vb under non-reducing conditions showed a single
band for the monomer (insertion of Fig. 1c). This indicates that the
homodimer in the solution is not formed by disulﬁde bond.
Meanwhile, the crystal structure shows a homodimer, which is
stabilized by the interactions in two sites (Fig. 7). Interactions in
site one (S1) mainly consist of hydrogen bonds between Lys31 in
monomer A and Asp49/Phe28 in monomer B (Fig. 7a, c and d). Site
two (S2) includes several hydrophobic interactions in the 60-loop,
H1 helix, Ca2+-loop and C-loop (Fig. 7b–d). S2 comprises the
interface-binding surface (i-face) of the PLA2. The examination of
the crystal unit-cell packing using the PISA software shows a
complete buried interface of 1582.3 Å2 (12.6% of the total surface
area), and DiG = 7.6 kcal/mol. The dimer in the structure is in a
grey area of complexation criteria; it may or not be stable in the
solution, which was consistent with the Superdex200 results.
4. Discussion
In this study, an acidic PLA2 called as PA2-Vb was isolated from
T. stejnegeri snake venom. The sequence alignment with other
snake PLA2s shows that PA2-Vb is an isoform of PLA2-V (Accession
Number: P82896) which was also puriﬁed from T. stejnegeri.
However, the biological characteristics of PLA2-V were largely
unknown. Here we show that PA2-Vb has a strong vasoconstriction
activity by acting on PAR-1.
In the vessel tension measurements, PA2-Vb was able to induce
a contractile response, in both high K+ and normal solutions. This
vasoconstriction effect was also found in other snake toxins, such
as natratoxin, a secreted PLA2 from Naja atra venom which can
effectively inhibit A-type K+ currents [12] and AhV_TL-I, a throm-
bin-like enzyme from A. halys pallas which acts on RyRs to evoke
Fig. 5. Electron density maps and sequence alignment of PA2-Vb. (a and b) The electron density maps (2Fo-Fc, r1.0) of the Ca2+-loop and the C-loop, respectively. (c) Multiple
alignments with other svPLA2s.
Fig. 6. Structure of PA2-Vb. (a) Ribbon representation of the PA2-Vb structure. (b and c) The PEG molecules in monomer (a) A and (b) B. The hydrogen bonds are shown in red
dot lines. The interacting amino acids are shown as thin sticks and the PEG molecules are shown as bold green sticks. The red and blue in the sticks represent oxygen atoms
and nitrogen atoms, respectively. The small red balls represent waters involved in the interaction.
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lar Ca2+ release mediated by IP3R results in vasoconstriction. In addi-
tion, PAR-1 and PLCb inhibitors both abolished the PA2-Vb-induced
vasoconstriction. This line of evidence indicates that PA2-Vb might
act on the PAR-1 receptor, leading to G protein activation. The
subsequently activation of PLCb to produce IP3 then activates
IP3R to mediate Ca2+ release and muscle cell contraction. Therefore,we have not only uncovered the working mechanism underlying
the PA2-Vb-induced vasoconstriction, but more importantly, we
have identiﬁed the molecular target of the PA2-Vb toxin in the
cells. In our previous study, AhV_TL-I was shown to indirectly
activate RyR [37]. Meanwhile, PAR-1-PLCb-IP3R-mediated Ca2+
release is involved in the vasoconstriction effect of PA2-Vb. This
new ﬁnding provides a new perspective on snake venom PLA2
Fig. 7. The interface of the homodimer. (a and b) The S1 site and S2 site as shown by LigPlot+ software. (c and d) The interface shown in monomer (a) A and monomer (b) B.
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resents a previously unknown function in svPLA2.
Because PA2-Vb is an enzyme, the protease inhibitor pBPB was
introduced to explore the relationship between its vasoconstric-
tion activity and its enzymatic activity. In most svPLA2s, the phar-
macological effects such as antibacterial and antiparasitic actions
are related to the products of hydrolysis [32]. But other activities
of svPLA2s were independent of their enzymatic activities. For
example, the treatment with pBPB strongly reduced the bacterici-
dal effect and partially decreased the neurotoxic effect of the
PLA2 from Crotalus durissus collilineatus venom [27]. In the present
study, even though the chemical modiﬁcation of His48 by pBPB in
PA2-Vb could dramatically inhibit the catalytic activity of the
enzyme, this modiﬁcation did not affect the PA2-Vb effect on the
vasoconstriction. This suggests that the vasoconstriction function
of PA2-Vb is independent of its enzymatic activity.
Finally, the crystal structure of PA2-Vb was determined at a
high resolution. It shows an overall fold typical of the PLA2 family
[1]. From gel ﬁltration, both monomer and homodimer are
observed in solution, which is consistent with the PISA prediction.
Homodimer is usually found in svPLA2 with different assembled
conformations. In BthTX-II structure, the homodimer is assembledby its H1 a-helix, b-wing and Leu110 from C [5]. While, the acidic
PLA2 from the venom of Deinagkistrodon acutus uses i-face to sta-
bilize the homodimer [9]. The oligomeric state is important for
some PLA2s [22]. In this study, the homodimer of PA2-Vb is also
stabilized by the interaction between the i-face of the two mole-
cules. The i-face of PLA2 is a planar surface which surrounds the
active site and binds to the phospholipid surface [35]. Previous
studies have described that the i-faces of PLA2s are structurally
and functionally different than their active sites. The substrate
accessibility of PLA2s can be facilitated by the contact between
the i-face and the interface of substrate. [29,35]. In PA2-Vb, the i-
face consists of a patch of hydrophobic residues surrounded by
polar residues and is involved in the binding of the phospholipid
membrane. In addition, the Lys31 of monomer A is inserted into
the active site of monomer B and forms several hydrogen bonds,
which is consistent with the phospholipid binding model [2]. It is
reported that PLA2 ﬁrst binds to the phospholipids membrane
through its i-face. Then, with the assistance of polar residues that
around the active sites, such as His48 or Lys69, the amphiphile
head group inserts into the catalytic pocket, like the Lys31 of mono-
mer A [33]. In PA2-Vb, four negative charged molecules, mapped as
PEG molecules, bond to the positive charged pocket. In svPLA2s,
F. Zeng et al. / FEBS Letters 588 (2014) 4604–4612 4611this positive charged patch was usually made up of the conven-
tional sequence: XBBBXXBX or XBBXBX in which B represents
basic amino acid and X represents non-basic amino acids [6]. How-
ever, the function of this positive pocket is still unknown.
In summary, we successfully isolated and puriﬁed an acidic
PLA2 named PA2-Vb from T. stejnegeri venom, and characterized
its vasoconstriction effect. Interestingly, we identify for the ﬁrst
time the molecular target of PA2-Vb in VSMCs, which acts on the
PAR-1 receptor. We also uncovered the mechanism underlying
the vasoconstriction through a PAR-1-PLCb-IP3R-Ca2+ release sig-
naling pathway. Finally, we solved the PA2-Vb crystal structure
at high resolution. Although it is unclear how PA2-Vb engages with
the PAR-1 receptor, our work shads light on the relationship of
animal toxins and Ca2+ homeostasis regulation.
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